Pharma Journalist -

Mustang Bio announced that it has opened a CAR T cell therapy manufacturing facility at UMass Medicine Science Park in Worcester, Mass. The 27,000 sq. ft. facility will support the…
Read More...

WuXi Biologics and Harbour BioMed announced an initial strategic collaboration for the development and manufacturing of Harbour's leading HCAb antibody. The collaboration with WuXi…
Read More...

Boehringer Ingelheim announced a 230 million euro investment into a new Biologicals Development Center (BDC) at the company’s Research and Development site in Biberach, Germany during…
Read More...

Samsung BioLogics announced that it has licensed by the Health Canada for manufacturing a monoclonal antibody Drug Substance at its first plant. This is a great milestone for…
Read More...

Syneos Health, the only fully integrated biopharmaceutical solutions organization, and Elligo Health Research, the only platform that brings clinical research direct to clinical health…
Read More...

Comprehend Systems announced it is joining the Veeva Partner Program. As a Veeva partner, Comprehend will integrate solutions with Veeva Vault EDC and Veeva Vault CTMS to provide…
Read More...

MeiraGTx announced it has been granted a Manufacturer’s Authorization for Investigational Medicinal Products from the United Kingdom’s Medicines and Healthcare products Regulatory…
Read More...

Aquinnah Pharmaceuticals announced that it has been awarded $3.4 million from the National Institute of Neurological Disorders and Stroke (NINDS) in a competing grant to advance novel…
Read More...

MaaT Pharma announced a licensing agreement under which MaaT Pharma will receive world-wide exclusive rights for the therapeutic application of allogeneic Fecal Microbiome Transplants…
Read More...

ImmunoGen, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for its lead program, mirvetuximab soravtansine. The designation is for the…
Read More...